Skip to main content
Sign In
 

ATDC 2014 Keystone Conference

Thursday, July 17, 2014 - Sunday, July 20, 2014



Wednesday, July 16, 2014

​5:00 – 7:00 PM     Early Registration

 

Thursday, July 17, 2014

12:00 – 12:15 PM    Welcome and Introductory Remarks: Satish Garg, MD

PLENARY ONE: Improving Diabetes Outcomes Chair - Matthew Riddle, MD

 12:15 –12:40 PM    

How Diabetes Outcomes Have Changed Over the Past 30 Years - Philip Home, MD AUDIO

 12:40 – 1:05 PM     

Why Obese People are Unable to Keep Weight Off after Losing itRobert Ratner, MD AUDIO

   1:05 – 1:30 PM      

What Should Be the Therapeutic Glycemic Target in Intensive Care Units?Irl Hirsch, MD AUDIO

   1:30 – 1:55 PM      

Contemporary Pediatric Diabetes Care - Tadej Battelino, MD AUDIO

PLENARY TWO: Controversies in Diabetes Chair - Robert Ratner, MD

   2:50 – 3:15 PM      

Should We Count Protein and Fat for Bolus Insulin Dose? Howard Wolpert, MD AUDIO

   3:15 – 3:40 PM     

Do Postprandial Glycemic Excursions Impact Cardiovascular Risk? V. Mohan, MD  AUDIO

   3:40 – 4:05 PM      

Role of Pramlintide in Diabetes CareMatthew Riddle, MD AUDIO

   4:05 – 4:30 PM      

Which Guidelines to Use for Gestational Diabetes – ACOG or ADA? - Linda Barbour, MD AUDIO


Friday, July 18, 2014

   7:55 – 8:05 AM      

Welcome and Introductory Remarks - Satish Garg, MD       

PLENARY THREE: Type 1 Diabetes – Immunology and Cell Therapy Chair - Philip Home, MD

  8:05 – 8:30 AM      

Knowledge gains in type 1 diabetes pathogenesis – New opportunities for the next generation of disease biomarkers Mark Atkinson, PhD AUDIO

  8:30 – 8:55 AM      

Is Primary Prevention a Realistic Expectation? Marian Rewers, PHD  AUDIO

  8:55 – 9:20 AM      

Immunomodulatory Trials; What Will Work? - Peter Gottlieb, MD AUDIO

  9:20 – 9:45 AM      

Tri-Molecular Complex for Immune Intervention?  - Aaron Michels, MD AUDIO 

  9:45 –10:10 AM      

Beta-Cell Regeneration or Replacement – Hype or Hope? - Jay Skyler, MD  AUDIO                               

PLENARY FOUR: Closed Loop Therapy – State of the Art  Chair - Georgeanna Klingensmith, MD

10:50 –11:15 AM     

Early Closed Loop Experience in Children - Tadej Battelino, MD AUDIO

 11:15 –11:40 AM    

Wearable Artificial PancreasBoris Kovatchev, PhD AUDIO

 11:40 –12:05 PM    

Making Diabetes Managem​ent Disappear: A Bionic Pancreas for One and All - Ed Damiano, PhD AUDIO

 12:05 –12:30 PM    

The Role of Glucagon in Closed Loop Treatment for T1D - Kenneth Ward, MD AUDIO

PLENARY FIVE: Diabetes Management Issues Chair - Sarit Polsky, MD

  2:00 – 2:25 PM       

Hypoglycemic Unawareness Philip Home, MD  AUDIO

  2:25 – 2:50 PM       

Explanation for the ACCORD Outcomes?Matthew Riddle, MD  AUDIO

  2:50 – 3:15 PM       

How to Successfully Manage T1DM in the Cheapest Way Possible Irl Hirsch, MD AUDIO

4:00 – 5:00 PM MEET THE PEERS SESSION (A&B Pediatrics, C&D Adult)

Session A. & B. Meet the Peers – Pediatric

A. Providers: Chairs - T. Battelino & R. Slover   

B. Educators: Chair -  R. Hink

Session C. & D. Meet the Peers – Adult

C. Providers: Chairs - P. Home & S. Garg

D. Educators: Chairs - C. Beatson & T. Thompson


Saturday, July 19, 2014

   7:50 – 7:55 AM      

Welcome and Introductory Remarks - Satish Garg, MD

   7:55 – 8:25 AM      

FDA’s Perspective on Closed-Loop Studies

Keynote Speaker: Courtney H. Lias, PhD; Director, Division of Chemistry and Toxicology Devices at FDA

PLENARY SIX: Special Issues in Diabetes Chair - Irl Hirsch, MD

   8:35 – 9:00 AM      

Role of Biosimilars in Diabetes Care Philip Home, MD AUDIO

   9:00 – 9:25 AM      

Role of CGM for Achieving Glycemic Targets - Howard Wolpert, MD AUDIO

   9:25 – 9:50 AM      

Fibrocalculous Pancreatic Diabetes - V. Mohan, MD AUDIO

 9:50 – 10:10 AM      

Management of T1D Using Telemedicine Paul Wadwa, MD   AUDIO                            

PLENARY SEVEN: Obesity and Type 2 Diabetes Chair - Linda Barbour, MD

10:45 –11:10 AM     

Role of Lifestyle ModificationsJames Hill, PhD  AUDIO

11:10 –11:35 AM     

Pharmacological Approaches to Weight Loss Daniel Bessesen, MD  AUDIO                              

11:35 –12:00 PM     

Role of Bariatric Surgery in Obesity & DiabetesPhillip Schauer, MD AUDIO

12:00 –12:30 PM     

Novel Approaches to Weight LossRobert Eckel, MD AUDIO

2:00 – 4:00 PM CONCURRENT SESSIONS 1 & 2

SESSION 1: Pediatric Diabetes Challenges Chair - Robert Slover, MD

2:00 – 2:20 PM   

Toddlers Peter Chase, MD

2:20 – 2:40 PM   

Teenagers G. Klingensmith, MD

2:40 – 3:00 PM   

T2D in Youth Tadej Battelino, MD

SESSION 2: Challenges with Diabetes Complications Chair - Satish Garg, MD

2:00 – 2:20 PM   

MicrovascularJay Skyler, MD

2:20 – 2:40 PM   

MacrovascularWill Hiatt, MD

2:40 – 3:00 PM   

Neuropathy​Daniel Bessesen, MD     

Patient/Provider Panel: Question & Answer Session

4:00 – 5:15 PM    

Pediatric Panel: R. Slover, G. Klingensmith, P. Chase, T. Battelino, M. Rewers 

Patients:

-Mollendor Family

-Zarecki Family

-Mario Medina

Adult Panel: S. Garg, A. Michels, J. Skyler, P. Gottlieb, H. Wolpert, I. Hirsch

Patients:

-Adam Smith

-Ted Miller

-Duncan Harvey & Robin Juarez

-Clark Eckel

-Lynda Bergeron

 

Sunday, July 20, 2014

  7:20 – 7:30 AM       

Opening Remarks Satish Garg, MD and Jay Skyler, MD

  7:30 – 8:00 AM       

Delivery of Quality Care in the Evolving Payor Landscape:

Keynote Speaker: Robert Ratner, MD  AUDIO

PLENARY EIGHT: Cardiovascular Disease and Diabetes Chair - Marian Rewers, PHD

   8:00 – 8:25 AM      

Is CVD Outcome for Diabetes Drugs Appropriate? - Will Hiatt, MD AUDIO

   8:25 – 8:50 AM      

Recent and Ongoing Cardiovascular Outcomes Trials with Diabetes Drugs - Jay Skyler, MD AUDIO

    8:50 – 9:15 AM      

Rationale for ADA Treatment Guidelines for CVD Prevention Robert Ratner, MD AUDIO

   9:15 – 9:40 AM      

Lipid Targets & Treatments 2014​ Robert Eckel, MD AUDIO​

10:10 –10:15 AM     

Concluding Remarks & Departures Satish Garg, MD